Gregory Rodgers

Phenomenelle Angels LLC (Phenomenelle Angels) is a venture capital firm founded in 2006 by Lauren A. Flanagan and Joe P. Hildebrandt. The firm is headquartered in Madison, Wisconsin.

Mason Wells Inc (Private Equity)(Mason Wells) is a private equity subsidiary of Marshall & Ilsley Corporation founded in 1998 by John Thomas Byrnes. The firm is headquartered in the Milwaukee, Wisconsin.

Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA.

VYV, Inc. designs, engineers, and manufactures germ-killing LED technology for an expanding range of commercial and residential applications. The company was founded by Colleen A. Costello and James Peterson and is headquartered in Troy, NY.

Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd

Merganser Biotech, Inc. engages in the development of of hepcidin mimetic peptides as new medicines for the treatment of hematological and iron overload diseases. The company was founded by Brian R. MacDonald and Gene Merutka in 2011 and is headquartered in Newtown Square, PA.

FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA.

eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA.

Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA.

Belle Capital Management LLC (Belle Capital) is a venture capital firm founded in 2010. The firm is headquartered in Gross Pointe Farms, Michigan.

GeneriCo LLC develops and markets generic drugs. The firm also has an embedded drug delivery technology, which used to make generic drugs to the targeted markets. Its products include pipeline and therapeutic areas. The company was founded by Thomas J. Brya, Michael Grimshaw, and Shu Zhu in 2013 and is headquartered in St. Louis, MO.

Founded in 1987, BioForward is a member-driven state association and venture capital investor located in Madison, Wisconsin. The firm serves as the voice of Wisconsin's bioscience industry. They advocate on their members behalf to create investment and partnership opportunities, attract and retain the best people and support public policy that fosters their continued growth. BioForward also provides member-support services including networking opportunities through a variety of conferences and events, online resources and group purchasing programs. Their members include bioscience companies, universities, non-profit organizations, service providers, as well as state, regional and local government representatives. BioForward was previously known as the Wisconsin Biotechnology & Medical Device Association.

Prolog Ventures LLC is a venture capital firm founded in 2000 by Brian Clevinger, Greg Johnson and Ilya Nykin. The firm is headquartered in Clayton, Missouri.

CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University.

BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri.

Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA.

Benson Hill Holdings, Inc. operates a crop design platform to develop sustainable food and ingredients. It offers CropOS (Crop Operating System), a cognitive engine that provides decision support to accelerate crop improvement and enhance the sustainability of food, feed, fiber, and fuel production using plant biology, big data analytics and cloud computing. The company was founded by Matthew B. Crisp, Todd Mockler and Thomas P. Brutnell in 2012 and is headquartered in St. Louis, MO.

Medsocket of Missouri, Inc. provides custom solutions to he health industry. Its services involve health-systems, healthcare providers, pharmaceutical clients, and agencies. The company was founded by Matt Botkin, Jayne Williams and Karl Kochendorfer in 2012 and is headquartered in Creve Coeur, MO.

Apse, Inc. offers technology and strategy services. It develops technology that will allow the cost efficient production of RNA for broad acre topical RNAi uses in agriculture. The company was founded by Juan Arhancet in 2011 and is headquartered in St. Louis, MO.

BacterioScan, Inc. manufacturers and sells in-vitro diagnostic products for lab and clinical care use. Its products include 216Dx UTI system and product pipeline. The firm also offers instrumentation platform that rapidly detects and measures microorganism growth in liquid specimens. The company was founded by Amnon Weichelbaum, Dan Regelman, and Daniel Hofmann in 2004 and is headquartered in St. Louis, MO.

Great Wolf Resorts Holdings, Inc. owns and operates indoor water parks and resorts. The firm offers arcade and game rooms, fitness rooms, themed restaurants, spas, supervised children's activities, and other amenities. The company was founded in 1997 and is headquartered in Chicago, IL.